Literature DB >> 6291866

Simultaneous simulation of the serum profiles of two antibiotics and analysis of the combined effect against a culture of Pseudomonas aeruginosa.

A Bauernfeind, R Jungwirth, C Petermüller.   

Abstract

The serum profiles of ceftriaxone (CEF) and netilmicin (NET) were produced in a liquid culture of Pseudomonas aeruginosa, and the change in viable count recorded. Synergism was detectable between CEF and NET despite of the widely disparate serum halflife times of NET and CEF.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6291866     DOI: 10.1159/000238100

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  9 in total

1.  [Antibacterial activity and beta-lactamase stability of eleven oral cephalosporins].

Authors:  A Bauernfeind; R Jungwirth; S Schweighart; M Theopold
Journal:  Infection       Date:  1990       Impact factor: 3.553

2.  [Dependence of the bactericidal activity and mutant selection of 4-quinolones on their serum concentration levels].

Authors:  A Bauernfeind; C Petermüller; B Heinrich; R Gablac
Journal:  Infection       Date:  1986       Impact factor: 3.553

3.  Selection of antibiotics for treatment and prophylaxis of staphylococcal infections in cystic fibrosis patients.

Authors:  A Bauernfeind; B Przyklenk; C Matthias; R Jungwirth; R M Bertele; K Harms
Journal:  Infection       Date:  1990 Mar-Apr       Impact factor: 3.553

4.  Killing of Pseudomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic model.

Authors:  J W Mouton; J G den Hollander
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

5.  Perspectives of beta-lactamases inhibitors in therapy of infections caused by Escherichia coli or Klebsiella with plasmidic resistance to third generation cephalosporins.

Authors:  A Bauernfeind
Journal:  Infection       Date:  1990 Jan-Feb       Impact factor: 3.553

Review 6.  Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  D M Richards; R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-06       Impact factor: 9.546

7.  Bacteriostatic and bactericidal activity of penicillins at constant and variable concentrations.

Authors:  A Bauernfeind
Journal:  Drugs       Date:  1985       Impact factor: 9.546

8.  Comparative pharmacodynamics of clarithromycin and azithromycin against respiratory pathogens.

Authors:  A Bauernfeind; R Jungwirth; E Eberlein
Journal:  Infection       Date:  1995 Sep-Oct       Impact factor: 3.553

9.  In vitro and in vivo synergy between ceftriaxone and aminoglycosides against Pseudomonas aeruginosa.

Authors:  P Angehrn
Journal:  Eur J Clin Microbiol       Date:  1983-10       Impact factor: 3.267

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.